Cargando…

FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century

Fibroblast activation protein (FAP), a type II transmembrane serine protease, is highly expressed in more than 90% of epithelial tumors and is closely associated with various tumor invasion, metastasis, and prognosis. Using FAP as a target, various FAP inhibitors (FAPIs) have been developed, most of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Rong, Pu, Yu, Huang, Shun, Yang, Conghui, Yang, Fake, Pu, Yongzhu, Li, Jindan, Chen, Long, Huang, Yunchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174525/ https://www.ncbi.nlm.nih.gov/pubmed/35692767 http://dx.doi.org/10.3389/fonc.2022.854658

Ejemplares similares

The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
por: Li, Jindan, et al.
Publicado: (2023)

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence
por: Jiang, Jie, et al.
Publicado: (2022)

FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors
por: Yang, Tianshuo, et al.
Publicado: (2022)

Dynamic PET/CT Imaging of (68)Ga-FAPI-04 in Chinese Subjects
por: Wang, Shuailiang, et al.
Publicado: (2021)

CAR‐T cell therapy for lung cancer: Potential and perspective
por: Chen, Long, et al.
Publicado: (2022)

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges
por: Hu, Qiuyuan, et al.
Publicado: (2023)

The value of AI in the Diagnosis, Treatment, and Prognosis of Malignant Lung Cancer
por: Wang, Yue, et al.
Publicado: (2022)

FAPI PET/CT Imaging—An Updated Review
por: Chandekar, Kunal Ramesh, et al.
Publicado: (2023)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
por: Chen, Long, et al.
Publicado: (2022)

Comparison of Diagnostic Efficacy of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET/CT for Staging and Restaging of Gastric Cancer
por: Zhang, Shumao, et al.
Publicado: (2022)

The clinical application of (18)F-FDG PET/CT in pancreatic cancer: a narrative review
por: Pu, Yongzhu, et al.
Publicado: (2021)

FAPI-04 Uptake in Healthy Tissues of Cancer Patients in (68)Ga-FAPI-04 PET/CT Imaging
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Diagnostic Value of (18)F-NOTA-FAPI PET/CT in a Rat Model of Radiation-Induced Lung Damage
por: Qin, Xueting, et al.
Publicado: (2022)

Prospective comparison of (68)Ga-FAPI-04 and (18)F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma
por: Ding, Haoyuan, et al.
Publicado: (2022)

Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT
por: Lin, Xinfeng, et al.
Publicado: (2023)

Solitary Fibrous Tumor of the Prostate Shown on FAPI PET/CT
por: Yang, Tianshuo, et al.
Publicado: (2023)

Localization of Pyelonephritis by (68)Ga-FAPI PET CT
por: Jagtap, Rajlaxmi Rangrao, et al.
Publicado: (2023)

Head-to-head comparison of (68)Ga-FAPI-04 PET/CT and (18)F-FDG PET/CT in the evaluation of primary digestive system cancer: a systematic review and meta-analysis
por: Ouyang, Jiqi, et al.
Publicado: (2023)

Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bone lymphoma
por: Pu, Yongzhu, et al.
Publicado: (2023)

A systematic review of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/CT in the diagnostic value of malignant tumor bone metastasis
por: Li, Lanying, et al.
Publicado: (2022)

Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
por: Qi, Na, et al.
Publicado: (2022)

FAPI-04 PET/CT Using [(18)F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient
por: Jiang, Xiao, et al.
Publicado: (2021)

Comparison of (68)Ga-FAPI and (18)F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer
por: Wu, Junhao, et al.
Publicado: (2022)

Case Report: (68)Ga-FAPI PET/CT, a more advantageous detection mean of gastric, peritoneal, and ovarian metastases from breast cancer
por: Li, Tianyue, et al.
Publicado: (2022)

Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
por: Gilardi, Laura, et al.
Publicado: (2022)

(68)Ga-FAPI-PET/CT in patients with various gynecological malignancies
por: Dendl, Katharina, et al.
Publicado: (2021)

Improved cancer detection in Waldeyer’s tonsillar ring by (68)Ga-FAPI PET/CT imaging
por: Serfling, S., et al.
Publicado: (2020)

Comparison of the Relative Diagnostic Performance of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG PET/CT for the Detection of Bone Metastasis in Patients With Different Cancers
por: Wu, Junhao, et al.
Publicado: (2021)

Comparison of (68)Ga-FAPI and (18)F-FDG PET/CT for the diagnosis of primary and metastatic lesions in abdominal and pelvic malignancies: A systematic review and meta-analysis
por: Liu, Xue, et al.
Publicado: (2023)

Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74
por: Glatting, Frederik M., et al.
Publicado: (2022)

Pneumonia with Intense (68)Ga-FAPI Uptake Mimicking Metastasis on (68)Ga-FAPI PET/CT in a Patient with Rectal Cancer
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2023)

(68)Ga-FAPI-04 PET/CT Findings in Patients with Liver Cirrhosis
por: Tatar, Gamze, et al.
Publicado: (2023)

(68)Ga- or (18)F-FAPI PET/CT—what it can and cannot
por: Mori, Yuriko, et al.
Publicado: (2023)

Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT
por: Koerber, Stefan A., et al.
Publicado: (2021)

The Added Value of (68)Ga-FAPI PET/CT in Patients with Head and Neck Cancer of Unknown Primary with (18)F-FDG–Negative Findings
por: Gu, Bingxin, et al.
Publicado: (2022)

Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
por: Elboga, Umut, et al.
Publicado: (2022)

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies
por: Dong, Yanzhao, et al.
Publicado: (2023)

[(18)F]FAPI-42 PET/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[(18)F]FDG PET/CT
por: Mu, Xingyu, et al.
Publicado: (2022)

In Vivo Fibroblast Activation of Systemic Sarcoidosis: A (68)Ga-FAPI-04 PET/CT Imaging Study
por: Wang, Jingnan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g773304tv8ihgp7l6uog4ltimv